Page 1 of Clinical Trials for Drug Brimonidine Tartrate Ophthalmic Solution, 40 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Last Updated: March 2, 2012
Condition(s): Allergic Conjunctivitis
2
Completed
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
Last Updated: August 4, 2008
Condition(s): Open-Angle Glaucoma; Ocular Hypertension
3
Completed
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Last Updated: January 31, 2012
Condition(s): Glaucoma; Ocular Hypertension
4
Completed
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
Last Updated: December 19, 2006
Condition(s): Healthy
5
Completed
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
Last Updated: February 22, 2006
Condition(s): Open Angle Glaucoma; Ocular Hypertension; Pseudoexfoliation Syndrome
6
Recruiting
A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
Last Updated: January 31, 2012
Condition(s): Glaucoma; Ocular Hypertension
7
Active, not recruiting
Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow
Last Updated: August 11, 2009
Condition(s): Glaucoma
8
Recruiting
Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma
Last Updated: October 3, 2011
Condition(s): Normal Tension Glaucoma
9
Completed
Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%
Last Updated: January 4, 2012
Condition(s): Erythematous Rosacea
10
Completed
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
Last Updated: August 17, 2011
Condition(s): Glaucoma; Ocular Hypertension
11
Recruiting
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Last Updated: May 14, 2012
Condition(s): Glaucoma, Open-Angle; Ocular Hypertension
12
Recruiting
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Last Updated: May 14, 2012
Condition(s): Glaucoma, Open-Angle; Ocular Hypertension
13
Recruiting
Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature
Last Updated: September 29, 2011
Condition(s): Primary Vascular Dysregulation
14
Not yet recruiting
Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Last Updated: January 24, 2012
Condition(s): Glaucoma; Ocular Hypertension
15
Recruiting
Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension
Last Updated: December 2, 2011
Condition(s): Glaucoma; Ocular Hypertension
16
Completed
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Last Updated: May 4, 2012
Condition(s): Open-angle Glaucoma; Ocular Hypertension
17
Completed
Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
Last Updated: October 16, 2007
Condition(s): Cataract
18
Completed
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Last Updated: April 1, 2008
Condition(s): Glaucoma; Ocular Hypertension
19
Completed
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
Last Updated: December 7, 2011
Condition(s): Glaucoma; Ocular Hypertension
20
Completed
Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
Last Updated: April 1, 2008
Condition(s): Glaucoma; Ocular Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Brimonidine+Tartrate+Ophthalmic+Solution

Page 1 of Clinical Trials for Drug Brimonidine Tartrate Ophthalmic Solution, 40 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About